Amenorrhea is the absence of menstrual bleeding in women of reproductive age. From the literature it is evident that not only chromosomal abnormalities contribute to the aetiology of amenorrhea but an underlying defect in the genes for the gonadotrophic hormones or their receptors could result in amenorrhea.
Introduction
Menstruation is the endpoint of a series of events which begin in the cerebral cortex and hypothalamus and terminates at the uterine and ovarian tissues in the hypothalamic-pituitaryovarian axis (HPO axis). Any break in this axis creates menstrual problems. Regular and spontaneous menstruation requires: a) an intact hypothalamic-pituitary-ovarian endocrine axis, b) an endometrium competent to respond to steroid hormone stimulation and c) an intact outflow tract from internal to external genitalia.
Menstrual disorders are one of the most commonly seen gynaecological problems in adolescent girls, composing 75% of such problems worldwide (Mittal et al., 2011) . Amenorrhea is only a symptom and not a disease entity. Amenorrhea can be physiological or pathological. Pathological amenorrhea can be the result of genetic variations, systemic diseases, endocrinopathies, disturbance of the HPO axis, gynatresia, nutritional factors, drug usage, psychological factors and other rarer causes.
Amenorrhea is clinically classified into two main types: primary and secondary. Primary Amenorrhea (PA) is clinically defined as the absence of menses by age 13 in the absence of normal growth and secondary sexual development; or the absence of menses by the age of 15 years in the setting of normal growth and secondary sexual development. Secondary amenorrhea (SA) is clinically defined as the absence of menses for more than 3 cycle intervals or 6 consecutive months in a previously menstruating woman.
In order to understand the main causes of amenorrhea, it is essential to understand the normal menstrual cycle, which begins in the hypothalamus with the pulsatile release of the Gonadotropin Releasing Hormone (GnRH). The GnRH reaches the anterior lobe of the pituitary gland where it stimulates the cells to secrete Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The FSH along with small amounts of LH stimulates the maturation of primodial follicles into Graafian follicles in the ovary. The mature Graafian follicle stimulates the secretion of estrogen and this in turn inhibits further production of FSH and stimulates production of LH from the anterior pituitary. Estrogen also causes proliferative changes in the uterine endometrium. The LH causes the mature Graafian follicle to rupture at ovulation and form the corpus leuteum. The corpus leuteum secretes progesterone which inhibits further production of LH and also stimulates the endometrium to undergo secretory hypertrophy. In the absence of pregnancy, the levels of estrogen and progesterone decrease gradually and the fall in the levels of these hormones restarts menstruation. A fall in the levels of these hormones also starts off a fresh positive feedback system and triggers the hypothalamus to release gonadotropins.
Based on this, the causes of amenorrhea can be categorized as follows: a functional or anatomic defect of the hypothalamus or pituitary (i.e., in the CNS), an anatomic or functional defect of the uterus and/or ovaries, or a genetic defect. A genetic defect can be at the chromosomal level or at a gene level.
In this study we have analyzed the types of chromosomal abnormalities seen in amenorrhea by karyotyping and discussed the various other options possible to investigate amenorrhea when the karyotype is reported to be normal. 
Main Research

Aim
To review the incidence and type of chromosomal abnormalities seen in patients with amenorrhea who were referred for karyotyping.
Patients and Materials
Karyotypes of patients referred with amenorrhea to the Division of Human Genetics, St. John's Medical College, Bangalore, from January 2006 to June 2012 were retrospectively analysed. The detailed medical history which was obtained at the time of referral was also looked into and noted. The initial diagnosis of PA or SA as made by the referring gynaecologist was followed up in the Division, based on the available medical history, which included clinical details, hormonal profile and ultrasonography (USG). The patients were in the age group of 13-30 years and included both unmarried as well as married females.
Methods
Routine analysis, by GTG banding, of the metaphases from peripheral blood lymphocytes, was performed using an Automated Karyotyping System (AKS). 25 metaphases were studied in each case and in the case of an abnormality the number of metaphases studied was increased to 50.
Results
Of the total number of patients with amenorrhea (n=317), 276 of them had a normal female karyotype (46,XX) and 41 of them had an abnormal karyotype which included 8 structural abnormalities, 24 numerical abnormalities and 9 cases of 46,XY(female)( Table 1) . Out of the total of 317 patients referred, 246 had Primary Amenorrhea (PA) and 71 had Secondary Amenorrhea (SA). The number of abnormalities seen in patients with PA (n=246) was 36 and in those with SA (n=71) was 5. The most common abnormality seen in patients with PA was 45,X (n=10). The abnormalities seen in SA were Turner variants and deletions. The typical Turner karyotype (45,X) was not seen in patients referred with SA.
Of the numerical abnormalities seen, the most commonly seen karyotype was 45,X (Turner Syndrome) (41.7%). 14 Turner variants were seen. Turner variants are those probands that have a mosaic cell line (i.e., 2 or more cell lines) of which one cell line has a 45,X karyotype. The structural abnormalities found included translocations (01), isochromosomes (01), inversions (01), and deletions (05).
Discussion
The most common abnormality seen in this study is Turner Syndrome and its variants (58.5%).
Karyotyping is an essential diagnostic test that needs to be done, not only to define the aetiology but also aid in management and counselling of the patient.
Reports have shown that the percentage of chromosomal abnormalities in patients referred with primary amenorrhea varies from 20%-30% (Joseph & Thomas, 1982; Opitz et al., 1983; Ten et al., 1990; Zheng et al., 2004; Wong and Lam; 2005; Rajangam and Nanjappa, 2007; Safaei et al., 2010; Vijayalakshmi et al., 2010; Kalavathi et al., 2010) . This means that a majority of the patients who had primary amenorrhea had a normal female karyotype. This highlights the fact that there are other causes other than chromosomal abnormalities to account for primary amenorrhea.
In accordance with already published literature, it was found that in this study also, 77.6% of the patients who had amenorrhea (both PA and SA) had a normal female karyotype, indicating that, in the absence of an anatomic hypothalamic or pituitary defect including tumours or a gross anatomic malformation of the uterus and/or ovaries, there could be an underlying genetic mutation causing the amenorrhea.
Conclusion
As seen from this study and previous studies (Table 2 ), a majority of females who presented with amenorrhea had a normal female karyotype (69.2% -89%), indicating that, in the absence of other causes like Mullerian agenesis, there could be an underlying factor at the gene level-particularly the genes coding for the hormones and receptors involved. (Joseph & Thomas, 1982; Opitz et al., 1983; Ten et al., 1990; Zheng et al., 2004; Wong and Lam; 2005; Rajangam and Nanjappa, 2007; Safaei et al., 2010; Vijayalakshmi et al., 2010; Kalavathi et al., 2010) .
The female menstrual cycle is determined by a complex interaction of hormones. The predominant hormones involved in the menstrual cycle are the gonadotropin releasing hormone, follicle stimulating hormone, luteinizing hormone, estrogen, and progesterone. As knowledge about the human genome and its sequencing has increased over the years, it became evident that genetic variations due to single nucleotide polymorphisms, called SNPs, are frequent in the hormones and receptors of the hypothalamic pituitary gonadal axis. It is likely that such genetic changes, as single SNPs or in various combinations, are capable of modifying the endocrine feedback systems and hormone action, resulting in variable inter-individual reproductive performance ranging from fully functional gametogenesis to infertility (Simoni et al., 2002) . For menstruation to take place normally, the functional and structural entirety of the hormones and their receptors of the HPO axis are very essential. For a hormone to function properly it is very crucial that the receptor of the hormone is also structurally and functionally sound. This is because cells communicate with each other through chemical signals. When a signalling molecule attaches itself to specific receptor sites, it sets off a series of chain reactions which is amplified at each level and finally culminates in a highly specific response (Ulloa-Aguirre & Timossi, 1998; Simoni et al., 2002 ) From this it is clear that a mutation or a polymorphism in either a hormone or its receptor will hinder the chain of reactions and thus alter the final outcome which, in this case could result in amenorrhea.
The World Health Organization has estimated 15% of the human population is infertile, and amenorrhea is the sixth largest major cause of female infertility (Rajangam & Nanjappa, 2007) . Genetic causes of male and female infertility have been attributed to inactivating mutations in the gonadotropin and gonadotropin receptor genes.
Mutations in the hormones and the receptors of the menstrual cycle have been found in patients with amenorrhea (Table 3) (Kalantaridou and Chrousos, 2002) . From this it can be concluded that the investigation of amenorrhea must not stop with karyotyping when a normal karyotype is obtained, but further investigation must be carried out to rule out genetic mutations being the cause for amenorrhea
